Rasandik Engineering Industries India Limited (BOM:522207)
India · Delayed Price · Currency is INR 91.59
-0.75 (-0.81%)
At close: Jul 31, 2025
Akoya Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -55.85 | 71.29 | -32.97 | -27.08 | -57.73 | Upgrade |
Depreciation & Amortization | 59.31 | 61.46 | 70.89 | 83.76 | 133.37 | Upgrade |
Loss (Gain) From Sale of Assets | -62.46 | -282.89 | -58.51 | -0.1 | - | Upgrade |
Provision & Write-off of Bad Debts | -2.06 | -13.55 | -0.88 | -3.12 | -13.4 | Upgrade |
Other Operating Activities | -42.5 | 80.88 | 94.21 | 98.25 | 96.57 | Upgrade |
Change in Accounts Receivable | 22.03 | 65.14 | 47.78 | 23.8 | -41.97 | Upgrade |
Change in Inventory | 120.45 | 138.5 | 74.28 | -56.13 | -64.56 | Upgrade |
Change in Accounts Payable | 14.22 | -44.04 | -73.09 | -1.14 | -10.4 | Upgrade |
Change in Other Net Operating Assets | -6.66 | -52.83 | 11.37 | 2.21 | -16.24 | Upgrade |
Operating Cash Flow | 46.5 | 23.96 | 133.07 | 120.45 | 25.65 | Upgrade |
Operating Cash Flow Growth | 94.04% | -81.99% | 10.47% | 369.59% | -89.51% | Upgrade |
Capital Expenditures | -8.34 | -12.18 | -34.34 | -8.91 | -3.33 | Upgrade |
Sale of Property, Plant & Equipment | 144.59 | 436.73 | 116.76 | 0.12 | - | Upgrade |
Other Investing Activities | 1.34 | 0.99 | -1.39 | 14.73 | 2.48 | Upgrade |
Investing Cash Flow | 137.59 | 425.54 | 81.02 | 5.93 | -0.86 | Upgrade |
Short-Term Debt Issued | - | - | 24.55 | - | 8.84 | Upgrade |
Long-Term Debt Issued | 25.32 | 25.4 | 17 | 190.2 | 47 | Upgrade |
Total Debt Issued | 25.32 | 25.4 | 41.55 | 190.2 | 55.84 | Upgrade |
Short-Term Debt Repaid | -126.11 | -309.06 | - | -31.49 | - | Upgrade |
Long-Term Debt Repaid | -56.28 | -72.04 | -146.89 | -178.16 | -5.39 | Upgrade |
Total Debt Repaid | -182.39 | -381.1 | -146.89 | -209.65 | -5.39 | Upgrade |
Net Debt Issued (Repaid) | -157.07 | -355.7 | -105.34 | -19.44 | 50.44 | Upgrade |
Other Financing Activities | -27.39 | -93.6 | -108.79 | -109.9 | -74.37 | Upgrade |
Financing Cash Flow | -184.46 | -449.3 | -214.13 | -129.34 | -23.93 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | - | - | -0.25 | Upgrade |
Net Cash Flow | -0.37 | 0.2 | -0.05 | -2.96 | 0.62 | Upgrade |
Free Cash Flow | 38.16 | 11.79 | 98.72 | 111.54 | 22.32 | Upgrade |
Free Cash Flow Growth | 223.71% | -88.06% | -11.49% | 399.77% | -90.70% | Upgrade |
Free Cash Flow Margin | 6.14% | 1.37% | 6.58% | 5.39% | 1.63% | Upgrade |
Free Cash Flow Per Share | 6.39 | 1.97 | 16.52 | 18.67 | 3.73 | Upgrade |
Cash Interest Paid | 27.39 | 93.6 | 108.79 | 109.9 | 74.37 | Upgrade |
Cash Income Tax Paid | -2.17 | -0.34 | -2.11 | 1.87 | -1.99 | Upgrade |
Levered Free Cash Flow | 243.64 | 58.89 | -66.25 | 21.46 | -23.29 | Upgrade |
Unlevered Free Cash Flow | 259.86 | 114.65 | -1.23 | 90.39 | 37.26 | Upgrade |
Change in Net Working Capital | -254.75 | -145.94 | 49.25 | 31.41 | 107.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.